The Joint Committee of Vaccination and Immunisation (JCVI) provided advice about the vaccination of children and young people aged 12 to 17 with follow-up advice for children aged 12 to 15.

The UK Chief Medical Officers (CMO's) recommend the coronavirus vaccine on public health grounds, given consideration of impacts such as education and mental health. The joint statement from the UK CMO's provides advice on the universal vaccination of children and young people aged 12 to 15 years against coronavirus.

How many doses will children and young people aged 12 to 17 years be offered?

Two doses of the vaccine (eight weeks apart) are recommended for:

  • those who are at increased risk from coronavirus due to underlying health conditions
  • those who live with someone who is immunosuppressed
  • those aged 16 or 17 years who are an unpaid carer, a frontline health or social care worker or are within three months of their 18th birthday

Two doses of the vaccine (12 weeks apart) are recommended for:

  • those aged 16 or 17 years who are not in an at-risk group. They should be offered a second dose of Pfizer-BioNTech vaccine. For those who have had COVID-19 and a first dose of vaccine, the second vaccine dose should be given 12 weeks or more following the first vaccine dose, or 12 weeks following infection, whichever is later.

Some children and young people are eligible for a third dose or a booster dose.

16-17 year olds

This cohort are now being encouraged to come forward for their booster jab. It is important to complete the immunisation course. 

Coronavirus in children and young people

For most children and young people, coronavirus is usually a milder illness that rarely leads to complications. For a very few the symptoms may last for longer than the usual two to three weeks.

Getting the vaccine will help to protect children and young people against coronavirus. Although most children and young people usually have mild illness, they can pass on their infection to others in their family and those they come into contact with.

Even if children and young people have already had coronavirus, they could still get it again. The vaccine will reduce their risk of getting coronavirus. If they do get it again, the vaccine can reduce how serious their symptoms will be.

Getting vaccinated

All children and young people aged 12 to 15 should have now have had their first Covid-19 vaccine.  Letters inviting this age group to have their second Covid-19 vaccine are being issued on 5 January 2022 with appointment dates scheduled for Saturday 15 and Sunday 16 January with a view to minimising any impact on schooling. 

Young people aged 16 and 17 should have already received an invitation letter. If you have not received an invitation letter you can register online.

Children and young people aged 12 to 17 can attend open access services to receive their vaccine. For a list of drop in clinics in Fife see our Drop in clinics page.

Rearranging your appointment

You can reschedule the date and time of your appointment if it does not suit by phoning the number on the letter but we are encouraging people to keep their appointment time if possible.

If you were contacted by your specialist, you should phone them to rearrange your appointment.

If your child or young person’s level of care needs or disability needs mean they cannot attend a clinic, phone the number on their invitation letter.


It's important for children and young people and their parents or carers discuss vaccination and come to a decision together.

Parents and carers are invited to accompany their children to their vaccine appointment and will have the opportunity to ask questions, and to discuss the benefits and risks of the vaccine.

We recommend you get agreement from your parent or carer, but it is not always necessary.

Information on consent from Public Health Scotland 

Vaccine safety

NHS Scotland only use vaccines that meet the required standards of safety and effectiveness. All medicines, including vaccines, are tested for safety and effectiveness before they’re allowed to be used. The Medicines and Healthcare products Regulatory Agency (MHRA) has to assess all the data and also ensure a vaccine works and that all the necessary trials and checks have been completed.

The MHRA will only approve a vaccine for supply in the UK if the expected standards of safety, quality and efficacy are met. The safety and effectiveness of the coronavirus vaccines continue to be checked while in use.

For more information visit NHS Inform.